Dual Activators of Protein Kinase R (PKR) and Protein Kinase R-Like Kinase (PERK) Identify Common and Divergent Catalytic Targets
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Activators of Protein Kinase R (PKR) and Protein Kinase R-Like Kinase (PERK) Identify Common and Divergent Catalytic Targets
Authors
Keywords
-
Journal
CHEMBIOCHEM
Volume 14, Issue 10, Pages 1255-1262
Publisher
Wiley
Online
2013-06-19
DOI
10.1002/cbic.201300177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor suppression by small molecule inhibitors of translation initiation
- (2015) Limo Chen et al. Oncotarget
- Uncoupling Proteostasis and Developmentin Vitrowith a Small Molecule Inhibitor of the Pancreatic Endoplasmic Reticulum Kinase, PERK
- (2012) Heather P. Harding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- (2012) Jeffrey M. Axten et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stress Granule Formation Induced by Measles Virus Is Protein Kinase PKR Dependent and Impaired by RNA Adenosine Deaminase ADAR1
- (2012) K. M. Okonski et al. JOURNAL OF VIROLOGY
- In vitro inhibition of translation initiation by N,N′-diarylureas—potential anti-cancer agents
- (2011) Séverine Denoyelle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PERK and PKR: Old kinases learn new tricks
- (2011) Jennifer F. Raven et al. CELL CYCLE
- The Early Interferon Response to Rotavirus Is Regulated by PKR and Depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3
- (2011) A. Sen et al. JOURNAL OF VIROLOGY
- Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target
- (2011) Ting Chen et al. Nature Chemical Biology
- Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity
- (2010) Abujiang Pataer et al. CANCER BIOLOGY & THERAPY
- Double-Stranded RNA-Dependent Protein Kinase Links Pathogen Sensing with Stress and Metabolic Homeostasis
- (2010) Takahisa Nakamura et al. CELL
- Structural Determinants of PERK Inhibitor Potency and Selectivity
- (2010) Hong Wang et al. Chemical Biology & Drug Design
- Regulation of innate immunity through RNA structure and the protein kinase PKR
- (2010) Subba Rao Nallagatla et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Embryonic Lethal Abnormal Vision-like HuR-dependent mRNA Stability Regulates Post-transcriptional Expression of Cyclin-dependent Kinase Inhibitor p27Kip1
- (2010) Gudrun Ziegeler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
- (2010) E Bobrovnikova-Marjon et al. ONCOGENE
- Wolcott-Rallison syndrome
- (2010) Cécile Julier et al. Orphanet Journal of Rare Diseases
- Multiple levels of PKR inhibition during HIV-1 replication
- (2010) Guerline Clerzius et al. REVIEWS IN MEDICAL VIROLOGY
- Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation
- (2009) Daorong Feng et al. BMC CELL BIOLOGY
- Interaction of Double-stranded RNA-dependent Protein Kinase (PKR) with the Death Receptor Signaling Pathway in Amyloid β (Aβ)-treated Cells and in APPSLPS1 Knock-in Mice
- (2009) Julien Couturier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53
- (2009) C.-H. Yoon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2 Phosphorylation Pathway
- (2009) Z. Mounir et al. Science Signaling
- PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control
- (2009) Ju-Il Kang et al. VIRUS RESEARCH
- Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition
- (2008) Helen L. Eley et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PKR is activated in MDS patients and its subcellular localization depends on disease severity
- (2008) M Y Follo et al. LEUKEMIA
- Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors
- (2008) Stefan Rothenburg et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease
- (2007) María J. Bullido et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now